{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T17:04:24Z","timestamp":1780074264983,"version":"3.54.0"},"reference-count":133,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"This publication was supported by internal research funding from the Jagiellonian University Medical College","award":["N43\/GBS\/000006"],"award-info":[{"award-number":["N43\/GBS\/000006"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharmacol. Rep"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s43440-026-00825-x","type":"journal-article","created":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T02:35:28Z","timestamp":1769135728000},"page":"391-404","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Metformin in skin diseases: the role of gut microbiota and immune response"],"prefix":"10.1007","volume":"78","author":[{"given":"Aneta","family":"Kiecka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Macura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marian","family":"Szczepanik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,23]]},"reference":[{"issue":"8","key":"825_CR1","first-page":"e67084","volume":"16","author":"CP Daniel","year":"2024","unstructured":"Daniel CP, Sittig KM, Wagner MJ, Cade C, Chriss W. Antibiotic treatment practices and microbial profile in diabetic foot ulcers: A retrospective cohort study. Cureus. 2024;16(8):e67084.","journal-title":"Cureus"},{"key":"825_CR2","doi-asserted-by":"publisher","first-page":"191","DOI":"10.3389\/fendo.2020.00191","volume":"11","author":"Z Lv","year":"2020","unstructured":"Lv Z, Guo Y. Metformin and its benefits for various diseases. Front Endocrinol (Lausanne). 2020;11:191.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"825_CR3","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1172\/JCI14178","volume":"108","author":"LA Witters","year":"2001","unstructured":"Witters LA. The blooming of the French lilac. J Clin Invest. 2001;108:1105\u20137.","journal-title":"J Clin Invest"},{"key":"825_CR4","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1002\/pdi.606","volume":"21","author":"CJ Bailey","year":"2004","unstructured":"Bailey CJ, Day C. Metformin: its botanical background. Pract Diabetes Int. 2004;21:115\u20137.","journal-title":"Pract Diabetes Int"},{"key":"825_CR5","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1007\/s00125-017-4318-z","volume":"60","author":"CJ Bailey","year":"2017","unstructured":"Bailey CJ. Metformin: historical overview. Diabetologia. 2017;60:1566\u201376.","journal-title":"Diabetologia"},{"issue":"1","key":"825_CR6","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s40200-024-01406-6","volume":"23","author":"J Andraos","year":"2024","unstructured":"Andraos J, Smith SR, Tran A, Pham DQ. Narrative review of data supporting alternate first-line therapies over metformin in type 2 diabetes. J Diabetes Metab Disord. 2024;23(1):385\u201394.","journal-title":"J Diabetes Metab Disord"},{"issue":"4","key":"825_CR7","doi-asserted-by":"publisher","first-page":"523","DOI":"10.3803\/EnM.2025.2371","volume":"40","author":"XL Wei","year":"2025","unstructured":"Wei XL, Tao MH, Li RH, Ge SH, Xiao W. Metformin and adipose tissue: A multifaceted regulator in metabolism, inflammation, and regeneration. Endocrinol Metab (Seoul). 2025;40(4):523\u201338.","journal-title":"Endocrinol Metab (Seoul)"},{"key":"825_CR8","volume-title":"Glucophage: serving diabetology for 40 years","author":"C Pasik","year":"1997","unstructured":"Pasik C. Diabetes and the biguanides: the mystery of each. In: Pasik C, editor. Glucophage: serving diabetology for 40 years. Volume 79. Lyon: Groupe Lipha; 1997."},{"issue":"13","key":"825_CR9","doi-asserted-by":"publisher","first-page":"3220","DOI":"10.3390\/cancers14133220","volume":"14","author":"L Di Magno","year":"2022","unstructured":"Di Magno L, Di Pastena F, Bordone R, Coni S, Canettieri G. The mechanism of action of biguanides: new answers to a complex question. Cancers (Basel). 2022;14(13):3220.","journal-title":"Cancers (Basel)"},{"key":"825_CR10","doi-asserted-by":"publisher","first-page":"1303844","DOI":"10.3389\/fphar.2023.1303844","volume":"14","author":"A Greco","year":"2023","unstructured":"Greco A, Coperchini F, Croce L, Magri F, Teliti M, Rotondi M. Drug repositioning in thyroid cancer treatment: the intriguing case of anti-diabetic drugs. Front Pharmacol. 2023;14:1303844.","journal-title":"Front Pharmacol"},{"issue":"9","key":"825_CR11","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1007\/s00125-017-4342-z","volume":"60","author":"G Rena","year":"2017","unstructured":"Rena G, Hardie DG, Pearson ER. The mechanisms of action of metformin. Diabetologia. 2017;60(9):1577\u201385.","journal-title":"Diabetologia"},{"key":"825_CR12","doi-asserted-by":"publisher","first-page":"558474","DOI":"10.3389\/fphar.2020.558474","volume":"11","author":"GDC Baeza-Flores","year":"2020","unstructured":"Baeza-Flores GDC, Guzm\u00e1n-Priego CG, Parra-Flores LI, Murbarti\u00e1n J, Torres-L\u00f3pez JE, Granados-Soto V. Metformin: a prospective alternative for the treatment of chronic pain. Front Pharmacol. 2020;11:558474.","journal-title":"Front Pharmacol"},{"key":"825_CR13","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1146\/annurev-med-062613-093128","volume":"66","author":"DR Morales","year":"2015","unstructured":"Morales DR, Morris AD. Metformin in cancer treatment and prevention. Annu Rev Med. 2015;66:17\u201329.","journal-title":"Annu Rev Med"},{"issue":"5","key":"825_CR14","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1007\/s00404-024-07379-4","volume":"309","author":"G Rashid","year":"2024","unstructured":"Rashid G, Khan NA, Elsori D, Youness RA, Hassan H, Siwan D, Seth N, Kamal MA, Rizvi S, Babker AM, Hafez W. miRNA expression in PCOS: unveiling a paradigm shift toward biomarker discovery. Arch Gynecol Obstet. 2024;309(5):1707\u201323.","journal-title":"Arch Gynecol Obstet"},{"issue":"3","key":"825_CR15","doi-asserted-by":"publisher","first-page":"577","DOI":"10.3390\/cancers14030577","volume":"14","author":"\u017b Kimber-Trojnar","year":"2022","unstructured":"Kimber-Trojnar \u017b, D\u0142uski DF, Wierzchowska-Opoka M, Rusza\u0142a M, Leszczy\u0144ska-Gorzelak B. Metformin as a potential treatment option for endometriosis. Cancers (Basel). 2022;14(3):577.","journal-title":"Cancers (Basel)"},{"issue":"11","key":"825_CR16","doi-asserted-by":"publisher","first-page":"550","DOI":"10.3390\/microorganisms7110550","volume":"7","author":"SR Ellis","year":"2019","unstructured":"Ellis SR, Nguyen M, Vaughn AR, Notay M, Burney WA, Sandhu S, Sivamani RK. The skin and gut Microbiome and its role in common dermatologic conditions. Microorganisms. 2019;7(11):550.","journal-title":"Microorganisms"},{"key":"825_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/164_2016_118","volume":"239","author":"B Greenwood-Van Meerveld","year":"2017","unstructured":"Greenwood-Van Meerveld B, Johnson AC, Grundy D. Gastrointestinal physiology and function. Handb Exp Pharmacol. 2017;239:1\u201316.","journal-title":"Handb Exp Pharmacol"},{"issue":"397","key":"825_CR18","doi-asserted-by":"publisher","first-page":"4651","DOI":"10.1126\/scitranslmed.aal4651","volume":"9","author":"AL Byrd","year":"2017","unstructured":"Byrd AL, Deming C, Cassidy SKB, Harrison OJ, Ng WI, Conlan S, Belkaid Y, Segre JA, Kong HH. Staphylococcus aureus and Staphylococcus epidermidis strain diversity underlying pediatric atopic dermatitis. Sci Transl Med. 2017;9(397):4651.","journal-title":"Sci Transl Med"},{"issue":"7689","key":"825_CR19","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/nature25177","volume":"553","author":"YE Chen","year":"2018","unstructured":"Chen YE, Fischbach MA, Belkaid Y. Skin microbiota-host interactions. Nature. 2018;553(7689):427\u201336.","journal-title":"Nature"},{"key":"825_CR20","doi-asserted-by":"publisher","first-page":"1345717","DOI":"10.3389\/fmicb.2024.1345717","volume":"15","author":"K Xue","year":"2024","unstructured":"Xue K, Zhang G, Li Z, Zeng X, Li Z, Wang F, Zhang X, Lin C, Mao C. Dissecting the association between gut microbiota and hypertrophic scarring: a bidirectional Mendelian randomization study. Front Microbiol. 2024;15:1345717.","journal-title":"Front Microbiol"},{"key":"825_CR21","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.3389\/fmicb.2018.01459","volume":"9","author":"I Salem","year":"2018","unstructured":"Salem I, Ramser A, Isham N, Ghannoum MA. The gut Microbiome as a major regulator of the gut-Skin axis. Front Microbiol. 2018;9:1459.","journal-title":"Front Microbiol"},{"issue":"4","key":"825_CR22","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.immuni.2017.04.008","volume":"46","author":"Y Belkaid","year":"2017","unstructured":"Belkaid Y, Harrison OJ. Homeostatic immunity and the microbiota. Immunity. 2017;46(4):562\u201376.","journal-title":"Immunity"},{"issue":"7545","key":"825_CR23","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/nature14052","volume":"520","author":"S Naik","year":"2015","unstructured":"Naik S, Bouladoux N, Linehan JL, Han SJ, Harrison OJ, Wilhelm C, Conlan S, Himmelfarb S, Byrd AL, Deming C, Quinones M, Brenchley JM, Kong HH, Tussiwand R, Murphy KM, Merad M, Segre JA, Belkaid Y. Commensal-dendritic-cell interaction specifies a unique protective skin immune signature. Nature. 2015;520(7545):104\u20138.","journal-title":"Nature"},{"key":"825_CR24","doi-asserted-by":"publisher","first-page":"1281660","DOI":"10.3389\/fmicb.2023.1281660","volume":"14","author":"Z Liu","year":"2023","unstructured":"Liu Z, Liu X. Gut microbiome, metabolome and alopecia areata. Front Microbiol. 2023;14:1281660.","journal-title":"Front Microbiol"},{"issue":"50","key":"825_CR25","doi-asserted-by":"publisher","first-page":"e36478","DOI":"10.1097\/MD.0000000000036478","volume":"102","author":"Y Shu","year":"2023","unstructured":"Shu Y, Li W, Hu Q, Xiong D. Bibliometrics and visual analysis of metformin and gut microbiota from 2012 to 2022: A systematic review. Med (Baltim). 2023;102(50):e36478.","journal-title":"Med (Baltim)"},{"key":"825_CR26","doi-asserted-by":"publisher","first-page":"958218","DOI":"10.3389\/fendo.2022.958218","volume":"13","author":"L Liu","year":"2022","unstructured":"Liu L, Zhang J, Cheng Y, Zhu M, Xiao Z, Ruan G, Wei Y. Gut microbiota: A new target for T2DM prevention and treatment. Front Endocrinol (Lausanne). 2022;13:958218.","journal-title":"Front Endocrinol (Lausanne)"},{"key":"825_CR27","doi-asserted-by":"publisher","first-page":"1477793","DOI":"10.3389\/fphar.2024.1477793","volume":"15","author":"L Natrus","year":"2024","unstructured":"Natrus L, Lisakovska O, Smirnov A, Osadchuk Y, Klys Y. Apoptotic and proliferative processes in the small intestine of rats with type 2 diabetes mellitus after metformin and propionic acid treatment. Front Pharmacol. 2024;15:1477793.","journal-title":"Front Pharmacol"},{"issue":"2","key":"825_CR28","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s42000-019-00093-w","volume":"18","author":"NG Vallianou","year":"2019","unstructured":"Vallianou NG, Stratigou T, Tsagarakis S. Metformin and gut microbiota: their interactions and their impact on diabetes. Horm (Athens). 2019;18(2):141\u20134.","journal-title":"Horm (Athens)"},{"issue":"2","key":"825_CR29","doi-asserted-by":"publisher","first-page":"198","DOI":"10.2337\/dc15-0488","volume":"39","author":"JB Buse","year":"2016","unstructured":"Buse JB, DeFronzo RA, Rosenstock J, Kim T, Burns C, Skare S, Baron A, Fineman M. The primary glucose-lowering effect of metformin resides in the gut, not the circulation: results from short-term Pharmacokinetic and 12-week dose-ranging studies. Diabetes Care. 2016;39(2):198\u2013205.","journal-title":"Diabetes Care"},{"issue":"7610","key":"825_CR30","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1038\/nature18848","volume":"535","author":"K Honda","year":"2016","unstructured":"Honda K, Littman DR. The microbiota in adaptive immune homeostasis and disease. Nature. 2016;535(7610):75\u201384.","journal-title":"Nature"},{"issue":"20","key":"825_CR31","doi-asserted-by":"publisher","first-page":"3447","DOI":"10.3390\/nu16203447","volume":"16","author":"OC Iatcu","year":"2024","unstructured":"Iatcu OC, Hamamah S, Covasa M. Harnessing prebiotics to improve type 2 diabetes outcomes. Nutrients. 2024;16(20):3447.","journal-title":"Nutrients"},{"issue":"7452","key":"825_CR32","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/nature12198","volume":"498","author":"FH Karlsson","year":"2013","unstructured":"Karlsson FH, Tremaroli V, Nookaew I, Bergstr\u00f6m G, Behre CJ, Fagerberg B, Nielsen J, B\u00e4ckhed F. Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature. 2013;498(7452):99\u2013103.","journal-title":"Nature"},{"issue":"2","key":"825_CR33","doi-asserted-by":"publisher","first-page":"e9085","DOI":"10.1371\/journal.pone.0009085","volume":"5","author":"N Larsen","year":"2010","unstructured":"Larsen N, Vogensen FK, van den Berg FW, Nielsen DS, Andreasen AS, Pedersen BK, Al-Soud WA, S\u00f8rensen SJ, Hansen LH, Jakobsen M. Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS ONE. 2010;5(2):e9085.","journal-title":"PLoS ONE"},{"issue":"8","key":"825_CR34","doi-asserted-by":"publisher","first-page":"e71108","DOI":"10.1371\/journal.pone.0071108","volume":"8","author":"X Zhang","year":"2013","unstructured":"Zhang X, Shen D, Fang Z, Jie Z, Qiu X, Zhang C, Chen Y, Ji L. Human gut microbiota changes reveal the progression of glucose intolerance. PLoS ONE. 2013;8(8):e71108.","journal-title":"PLoS ONE"},{"issue":"9","key":"825_CR35","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1136\/gutjnl-2014-306928","volume":"63","author":"H Tilg","year":"2014","unstructured":"Tilg H, Moschen AR. Microbiota and diabetes: an evolving relationship. Gut. 2014;63(9):1513\u201321.","journal-title":"Gut"},{"issue":"1","key":"825_CR36","doi-asserted-by":"publisher","first-page":"54","DOI":"10.2337\/dc16-1324","volume":"40","author":"J de la Cuesta-Zuluaga","year":"2017","unstructured":"de la Cuesta-Zuluaga J, Mueller NT, Corrales-Agudelo V, Vel\u00e1squez-Mej\u00eda EP, Carmona JA, Abad JM, Escobar JS. Metformin is associated with higher relative abundance of mucin-degrading Akkermansia muciniphila and several short-chain fatty acid-producing microbiota in the gut. Diabetes Care. 2017;40(1):54\u201362.","journal-title":"Diabetes Care"},{"issue":"10","key":"825_CR37","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1007\/s00125-015-3712-7","volume":"58","author":"NM Delzenne","year":"2015","unstructured":"Delzenne NM, Cani PD, Everard A, Neyrinck AM, Bindels LB. Gut microorganisms as promising targets for the management of type 2 diabetes. Diabetologia. 2015;58(10):2206\u201317.","journal-title":"Diabetologia"},{"key":"825_CR38","doi-asserted-by":"publisher","first-page":"101805","DOI":"10.1016\/j.molmet.2023.101805","volume":"77","author":"P Petakh","year":"2023","unstructured":"Petakh P, Kamyshna I, Kamyshnyi A. Effects of metformin on the gut microbiota: A systematic review. Mol Metab. 2023;77:101805.","journal-title":"Mol Metab"},{"issue":"9","key":"825_CR39","doi-asserted-by":"publisher","first-page":"e0204317","DOI":"10.1371\/journal.pone.0204317","volume":"13","author":"I Elbere","year":"2018","unstructured":"Elbere I, Kalnina I, Silamikelis I, Konrade I, Zaharenko L, Sekace K, Radovica-Spalvina I, Fridmanis D, Gudra D, Pirags V, Klovins J. Association of metformin administration with gut Microbiome dysbiosis in healthy volunteers. PLoS ONE. 2018;13(9):e0204317.","journal-title":"PLoS ONE"},{"issue":"6","key":"825_CR40","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1007\/s00125-019-4848-7","volume":"62","author":"T Bryrup","year":"2019","unstructured":"Bryrup T, Thomsen CW, Kern T, Allin KH, Brandslund I, J\u00f8rgensen NR, Vestergaard H, Hansen T, Hansen TH, Pedersen O, Nielsen T. Metformin-induced changes of the gut microbiota in healthy young men: results of a non-blinded, one-armed intervention study. Diabetologia. 2019;62(6):1024\u201335.","journal-title":"Diabetologia"},{"issue":"19","key":"825_CR41","doi-asserted-by":"publisher","first-page":"5935","DOI":"10.1128\/AEM.01357-14","volume":"80","author":"H Lee","year":"2014","unstructured":"Lee H, Ko G. Effect of metformin on metabolic improvement and gut microbiota. Appl Environ Microbiol. 2014;80(19):5935\u201343.","journal-title":"Appl Environ Microbiol"},{"issue":"7612","key":"825_CR42","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1038\/nature18646","volume":"535","author":"HK Pedersen","year":"2016","unstructured":"Pedersen HK, Gudmundsdottir V, Nielsen HB, Hyotylainen T, Nielsen T, Jensen BA, Forslund K, Hildebrand F, Prifti E, Falony G, Le Chatelier E, Levenez F, Dor\u00e9 J, Mattila I, Plichta DR, P\u00f6h\u00f6 P, Hellgren LI, Arumugam M, Sunagawa S, Vieira-Silva S, J\u00f8rgensen T, Holm JB, Tro\u0161t K, MetaHIT C, Kristiansen K, Brix S, Raes J, Wang J, Hansen T, Bork P, Brunak S, Oresic M, Ehrlich SD, Pedersen O. Human gut microbes impact host serum metabolome and insulin sensitivity. Nature. 2016;535(7612):376\u201381.","journal-title":"Nature"},{"issue":"7606","key":"825_CR43","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nature18309","volume":"534","author":"RJ Perry","year":"2016","unstructured":"Perry RJ, Peng L, Barry NA, Cline GW, Zhang D, Cardone RL, Petersen KF, Kibbey RG, Goodman AL, Shulman GI. Acetate mediates a microbiome-brain-\u03b2-cell axis to promote metabolic syndrome. Nature. 2016;534(7606):213\u20137.","journal-title":"Nature"},{"key":"825_CR44","doi-asserted-by":"publisher","first-page":"112723","DOI":"10.1016\/j.foodres.2023.112723","volume":"167","author":"J Vily-Petit","year":"2023","unstructured":"Vily-Petit J, Soty M, Silva M, Micoud M, Bron C, Gu\u00e9rin-Deremaux L, Mithieux G. Improvement of energy metabolism associated with NUTRIOSE\u00ae soluble fiber, a dietary ingredient exhibiting prebiotic properties, requires intestinal gluconeogenesis. Food Res Int. 2023;167:112723.","journal-title":"Food Res Int"},{"issue":"8","key":"825_CR45","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1007\/s00125-016-3992-6","volume":"59","author":"RA DeFronzo","year":"2016","unstructured":"DeFronzo RA, Buse JB, Kim T, Burns C, Skare S, Baron A, Fineman M. Once-daily delayed-release metformin lowers plasma glucose and enhances fasting and postprandial GLP-1 and PYY: results from two randomised trials. Diabetologia. 2016;59(8):1645\u201354.","journal-title":"Diabetologia"},{"key":"825_CR46","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s13098-017-0299-9","volume":"9","author":"PM Ryan","year":"2017","unstructured":"Ryan PM, Stanton C, Caplice NM. Bile acids at the cross-roads of gut microbiome-host cardiometabolic interactions. Diabetol Metab Syndr. 2017;9:102.","journal-title":"Diabetol Metab Syndr"},{"issue":"7","key":"825_CR47","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1111\/apt.13333","volume":"42","author":"P Pavlidis","year":"2015","unstructured":"Pavlidis P, Powell N, Vincent RP, Ehrlich D, Bjarnason I, Hayee B. Systematic review: bile acids and intestinal inflammation-luminal aggressors or regulators of mucosal defence? Aliment Pharmacol Ther. 2015;42(7):802\u201317.","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"825_CR48","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1080\/19490976.2015.1127483","volume":"7","author":"JM Ridlon","year":"2016","unstructured":"Ridlon JM, Harris SC, Bhowmik S, Kang DJ, Hylemon PB. Consequences of bile salt biotransformations by intestinal bacteria. Gut Microbes. 2016;7(1):22\u201339.","journal-title":"Gut Microbes"},{"issue":"8","key":"825_CR49","doi-asserted-by":"publisher","first-page":"945","DOI":"10.2174\/1389450118666170613081730","volume":"19","author":"M Schuiveling","year":"2018","unstructured":"Schuiveling M, Vazirpanah N, Radstake TRDJ, Zimmermann M, Broen JCA. Metformin, a new era for an old drug in the treatment of immune mediated disease? Curr Drug Targets. 2018;19(8):945\u201359.","journal-title":"Curr Drug Targets"},{"key":"825_CR50","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.3389\/fimmu.2018.01605","volume":"9","author":"A Angajala","year":"2018","unstructured":"Angajala A, Lim S, Phillips JB, Kim JH, Yates C, You Z, Tan M. Diverse roles of mitochondria in immune responses: novel insights into immuno-metabolism. Front Immunol. 2018;9:1605.","journal-title":"Front Immunol"},{"key":"825_CR51","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1530\/EJE-15-0572","volume":"173","author":"VM Victor","year":"2015","unstructured":"Victor VM, Rovira-Llopis S, Ba\u00f1uls C, Diaz-Morales N, Castell\u00f3 R, Falc\u00f3n R, Gomez M, Rocha M, Hernandez-Mijares A. Effects of metformin on mitochondrial function of leukocytes from polycystic ovary syndrome patients with insulin resistance. Eur J Endocrinol. 2015;173:683\u201391.","journal-title":"Eur J Endocrinol"},{"key":"825_CR52","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.cmet.2018.09.019","volume":"29","author":"S Soberanes","year":"2019","unstructured":"Soberanes S, Misharin AV, Jairaman A, Morales-Nebreda L, McQuattie-Pimentel AC, Cho T, Hamanaka RB, Meliton AY, Reyfman PA, Walter JM, Chen CI, Chi M, Chiu S, Gonzalez-Gonzalez FJ, Antalek M, Abdala-Valencia H, Chiarella SE, Sun KA, Woods PS, Ghio AJ, Jain M, Perlman H, Ridge KM, Morimoto RI, Sznajder JI, Balch WE, Bhorade SM, Bharat A, Prakriya M, Chandel NS, Mutlu GM, Scott Budinger GR. metformin targets mitochondrial electron transport to reduce air-pollution-induced thrombosis. Cell Metab. 2019;29:335\u201347.","journal-title":"Cell Metab"},{"key":"825_CR53","doi-asserted-by":"publisher","first-page":"2056","DOI":"10.3389\/fimmu.2020.02056","volume":"11","author":"X Chen","year":"2020","unstructured":"Chen X, Guo H, Qiu L, Zhang C, Deng Q, Leng Q. Immunomodulatory and antiviral activity of metformin and its potential implications in treating coronavirus disease 2019 and lung injury. Front Immunol. 2020;11:2056.","journal-title":"Front Immunol"},{"key":"825_CR54","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.3389\/fimmu.2018.01236","volume":"9","author":"F Ursini","year":"2018","unstructured":"Ursini F, Russo E, Pellino G, D\u2019Angelo S, Chiaravalloti A, De Sarro G. Metformin and autoimmunity: a new deal of an old drug. Front Immunol. 2018;9:1236.","journal-title":"Front Immunol"},{"issue":"33","key":"825_CR55","doi-asserted-by":"publisher","first-page":"20348","DOI":"10.1074\/jbc.M115.662114","volume":"290","author":"B Kelly","year":"2015","unstructured":"Kelly B, Tannahill GM, Murphy MP, O\u2019Neill LA. Metformin inhibits the production of reactive oxygen species from NADH:ubiquinone oxidoreductase to limit induction of interleukin-1\u03b2 (IL-1\u03b2) and boosts interleukin-10 (IL-10) in lipopolysaccharide (LPS)-activated macrophages. J Biol Chem. 2015;290(33):20348\u201359.","journal-title":"J Biol Chem"},{"key":"825_CR56","doi-asserted-by":"publisher","first-page":"14928","DOI":"10.1038\/s41598-020-71946-3","volume":"10","author":"I Nojima","year":"2020","unstructured":"Nojima I, Eikawa S, Tomonobu N, Hada Y, Kajitani N, Teshigawara S, Miyamoto S, Tone A, Uchida HA, Nakatsuka A. Dysfunction of CD8 PD-1 T cells in type 2 diabetes caused by the impairment of metabolism-immune axis. Sci Rep. 2020;10:14928.","journal-title":"Sci Rep"},{"key":"825_CR57","doi-asserted-by":"publisher","first-page":"109458","DOI":"10.1016\/j.biopha.2019.109458","volume":"120","author":"P Xu","year":"2019","unstructured":"Xu P, Yin K, Tang X, Tian J, Zhang Y, Ma J, Xu H, Xu Q, Wang. Metformin inhibits the function of granulocytic myeloid-derived suppressor cells in tumor-bearing mice. Biomed Pharmacother. 2019;120:109458.","journal-title":"Biomed Pharmacother"},{"issue":"12","key":"825_CR58","doi-asserted-by":"publisher","first-page":"2881","DOI":"10.3390\/cancers14122881","volume":"14","author":"J Kang","year":"2022","unstructured":"Kang J, Lee D, Lee KJ, Yoon JE, Kwon JH, Seo Y, Kim J, Chang SY, Park J, Kang EA, Park SJ, Park JJ, Cheon JH, Kim TI. Tumor-suppressive effect of metformin via the regulation of M2 macrophages and myeloid-derived suppressor cells in the tumor microenvironment of colorectal cancer. Cancers (Basel). 2022;14(12):2881.","journal-title":"Cancers (Basel)"},{"issue":"9","key":"825_CR59","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.4049\/jimmunol.1901213","volume":"204","author":"Z Zhang","year":"2020","unstructured":"Zhang Z, Li F, Tian Y, Cao L, Gao Q, Zhang C, Zhang K, Shen C, Ping Y, Maimela NR, Wang L, Zhang B, Zhang Y. Metformin enhances the antitumor activity of CD8+ T lymphocytes via the AMPK-miR-107-Eomes-PD-1 pathway. J Immunol. 2020;204(9):2575\u201388.","journal-title":"J Immunol"},{"key":"825_CR60","first-page":"115","volume":"23","author":"C Avena-Woods","year":"2017","unstructured":"Avena-Woods C. Overview of atopic dermatitis. Am J Manag Care. 2017;23:115\u201323.","journal-title":"Am J Manag Care"},{"issue":"1","key":"825_CR61","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s40659-020-00316-0","volume":"53","author":"J Gao","year":"2020","unstructured":"Gao J, Chen F, Fang H, Mi J, Qi Q, Yang M. Daphnetin inhibits proliferation and inflammatory response in human HaCaT keratinocytes and ameliorates imiquimod-induced psoriasis-like skin lesion in mice. Biol Res. 2020;53(1):48.","journal-title":"Biol Res"},{"issue":"5","key":"825_CR62","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1007\/s10787-020-00704-8","volume":"28","author":"SY Choi","year":"2020","unstructured":"Choi SY, Lee C, Heo MJ, Choi YM, An IS, Bae S, An S, Jung JH. Metformin ameliorates animal models of dermatitis. Inflammopharmacology. 2020;28(5):1293\u2013300.","journal-title":"Inflammopharmacology"},{"key":"825_CR63","doi-asserted-by":"crossref","unstructured":"Pei X, Ling Y, Zhu K, Chen W, Gu M. Metformin attenuates atopic dermatitis by inhibiting CD40 expression in CD11c\u2009+\u2009DC via the mTOR pathway 2017;9(6):934\u2013940.","DOI":"10.1166\/nnl.2017.2402"},{"issue":"1","key":"825_CR64","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jaad.2005.01.010","volume":"54","author":"UR Hengge","year":"2006","unstructured":"Hengge UR, Ruzicka T, Schwartz RA, Cork MJ. Adverse effects of topical glucocorticosteroids. J Am Acad Dermatol. 2006;54(1):1\u201315. quiz 16\u2009\u2013\u20098.","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"825_CR65","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1159\/000501583","volume":"236","author":"NS Haddadi","year":"2020","unstructured":"Haddadi NS, Shakiba S, Afshari K, Haj-Mirzaian A, Vesaghati S, Gharagozlou S, Foroumadi R, Shafaroodi H, Ostadhadi S, Dehpour AR. Possible involvement of nitric oxide in the antipruritic effect of metformin on chloroquine-induced scratching in mice. Dermatology. 2020;236(2):151\u20139.","journal-title":"Dermatology"},{"key":"825_CR66","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1097\/ACI.0000000000000142","volume":"15","author":"SF Martin","year":"2015","unstructured":"Martin SF. Immunological mechanisms in allergic contact dermatitis. Curr Opin Allergy Clin Immunol. 2015;15:124\u201330.","journal-title":"Curr Opin Allergy Clin Immunol"},{"issue":"1","key":"825_CR67","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1248\/bpb.b19-00689","volume":"43","author":"M Wang","year":"2020","unstructured":"Wang M, Qu S, Ma J, Wang X, Yang Y. Metformin suppresses LPS-induced inflammatory responses in macrophage and ameliorates allergic contact dermatitis in mice via autophagy. Biol Pharm Bull. 2020;43(1):129\u201337.","journal-title":"Biol Pharm Bull"},{"key":"825_CR68","unstructured":"Chen SH, Zhou ZZ, Lian N, Chen YJ, Long FY, Li M, Gu H, Chen X. Metformin alleviates DNCB-induced contact dermatitis in mice by inhibiting necroptosis of keratinocytes. 2015;13."},{"key":"825_CR69","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/s41420-020-0245-8","volume":"6","author":"G Tsuji","year":"2020","unstructured":"Tsuji G, Hashimoto-Hachiya A, Yen VH, Takemura M, Yumine A, Furue K, Furue M, Nakahara T. Metformin inhibits IL-1\u03b2 secretion via impairment of NLRP3 inflammasome in keratinocytes: implications for preventing the development of psoriasis. Cell Death Discov. 2020;6:11.","journal-title":"Cell Death Discov"},{"key":"825_CR70","unstructured":"Deng Y, Jiang S, Huang Y, Tan X, Huang Y, Chen L, Xu J, Xiong X, Zhou J, Xu Y. Metformin contributes to the therapeutic effects of acne vulgaris by modifying the gut microbiome."},{"issue":"22","key":"825_CR71","doi-asserted-by":"publisher","first-page":"14985","DOI":"10.3390\/ijerph192214985","volume":"19","author":"AE Ahmed","year":"2022","unstructured":"Ahmed AE, Alsamghan A, Momenah MA, Alqhtani HA, Aldawood NA, Alshehri MA, Ali Alshehri AM, Alhag SK, Mosaad YO, Ahmed H. Metabolic syndrome and cardiometabolic risk factors in the mixed hypercholesterolemic populations with respect to Gender, Age, and obesity in Asir, Saudi Arabia. Int J Environ Res Public Health. 2022;19(22):14985.","journal-title":"Int J Environ Res Public Health"},{"issue":"7","key":"825_CR72","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1038\/nm.4345","volume":"23","author":"H Wu","year":"2017","unstructured":"Wu H, Esteve E, Tremaroli V, Khan MT, Caesar R, Manner\u00e5s-Holm L, St\u00e5hlman M, Olsson LM, Serino M, Planas-F\u00e8lix M, Xifra G, Mercader JM, Torrents D, Burcelin R, Ricart W, Perkins R, Fern\u00e0ndez-Real JM, B\u00e4ckhed F. Metformin alters the gut Microbiome of individuals with treatment-naive type 2 diabetes, contributing to the therapeutic effects of the drug. Nat Med. 2017;23(7):850\u20138.","journal-title":"Nat Med"},{"issue":"11","key":"825_CR73","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1111\/jdv.12116","volume":"27","author":"D Badr","year":"2013","unstructured":"Badr D, Kurban M, Abbas O. Metformin in dermatology: an overview. J Eur Acad Dermatol Venereol. 2013;27(11):1329\u201335.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"825_CR74","doi-asserted-by":"publisher","first-page":"4","DOI":"10.4103\/0253-7613.174388","volume":"48","author":"AK Bubna","year":"2016","unstructured":"Bubna AK. Metformin - for the dermatologist. Indian J Pharmacol. 2016;48(1):4\u201310.","journal-title":"Indian J Pharmacol"},{"key":"825_CR75","doi-asserted-by":"publisher","first-page":"18392","DOI":"10.2340\/actadv.v103.18392","volume":"103","author":"M Cho","year":"2023","unstructured":"Cho M, Woo YR, Cho SH, Lee JD, Kim HS, Metformin. A potential treatment for acne, hidradenitis suppurativa and rosacea. Acta Derm Venereol. 2023;103:18392.","journal-title":"Acta Derm Venereol"},{"issue":"4","key":"825_CR76","doi-asserted-by":"publisher","first-page":"3993","DOI":"10.18632\/aging.102787","volume":"12","author":"K Chen","year":"2020","unstructured":"Chen K, Li Y, Guo Z, Zeng Y, Zhang W, Wang H. Metformin: current clinical applications in nondiabetic patients with cancer. Aging. 2020;12(4):3993\u20134009.","journal-title":"Aging"},{"issue":"4","key":"825_CR77","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1210\/clinem\/dgaa951","volume":"106","author":"M Hu","year":"2021","unstructured":"Hu M, Zhang Y, Li X, Cui P, Sferruzzi-Perri AN, Br\u00e4nnstr\u00f6m M, Shao LR, Billig H. TLR4-Associated IRF-7 and NF\u03baB signaling act as a molecular link between androgen and Metformin activities and cytokine synthesis in the PCOS endometrium. J Clin Endocrinol Metab. 2021;106(4):1022\u201340.","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"825_CR78","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s12958-021-00765-6","volume":"19","author":"M Ohara","year":"2021","unstructured":"Ohara M, Yoshida-Komiya H, Ono-Okutsu M, Yamaguchi-Ito A, Takahashi T, Fujimori K. Metformin reduces androgen receptor and upregulates homeobox A10 expression in uterine endometrium in women with polycystic ovary syndrome. Reprod Biol Endocrinol. 2021;19(1):77.","journal-title":"Reprod Biol Endocrinol"},{"key":"825_CR79","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.mce.2014.08.012","volume":"399","author":"M Tadakawa","year":"2015","unstructured":"Tadakawa M, Takeda T, Li B, Tsuiji K, Yaegashi N. The anti-diabetic drug Metformin inhibits vascular endothelial growth factor expression via the mammalian target of Rapamycin complex 1\/hypoxia-inducible factor-1\u03b1 signaling pathway in ELT-3 cells. Mol Cell Endocrinol. 2015;399:1\u20138.","journal-title":"Mol Cell Endocrinol"},{"issue":"6","key":"825_CR80","first-page":"1873","volume":"27","author":"H Liao","year":"2012","unstructured":"Liao H, Zhou Q, Gu Y, Duan T, Feng Y. Luteinizing hormone facilitates angiogenesis in ovarian epithelial tumor cells and metformin inhibits the effect through the mTOR signaling pathway. Oncol Rep. 2012;27(6):1873\u20138.","journal-title":"Oncol Rep"},{"issue":"5","key":"825_CR81","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1593\/neo.11148","volume":"13","author":"R Rattan","year":"2011","unstructured":"Rattan R, Graham RP, Maguire JL, Giri S, Shridhar V. Metformin suppresses ovarian cancer growth and metastasis with enhancement of cisplatin cytotoxicity in vivo. Neoplasia. 2011;13(5):483\u201391.","journal-title":"Neoplasia"},{"issue":"3","key":"825_CR82","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1093\/cvr\/cvq066","volume":"87","author":"H Xiao","year":"2010","unstructured":"Xiao H, Ma X, Feng W, Fu Y, Lu Z, Xu M, Shen Q, Zhu Y, Zhang Y. Metformin attenuates cardiac fibrosis by inhibiting the TGFbeta1-Smad3 signalling pathway. Cardiovasc Res. 2010;87(3):504\u201313.","journal-title":"Cardiovasc Res"},{"issue":"9","key":"825_CR83","doi-asserted-by":"publisher","first-page":"7045","DOI":"10.1002\/jcp.26505","volume":"233","author":"H Yi","year":"2018","unstructured":"Yi H, Huang C, Shi Y, Cao Q, Zhao Y, Zhang L, Chen J, Pollock CA, Chen XM. Metformin attenuates folic-acid induced renal fibrosis in mice. J Cell Physiol. 2018;233(9):7045\u201354.","journal-title":"J Cell Physiol"},{"key":"825_CR84","doi-asserted-by":"publisher","first-page":"28597","DOI":"10.1038\/srep28597","volume":"6","author":"H Xiao","year":"2016","unstructured":"Xiao H, Zhang J, Xu Z, Feng Y, Zhang M, Liu J, Chen R, Shen J, Wu J, Lu Z, Fang X, Li J, Zhang Y. Metformin is a novel suppressor for transforming growth factor (TGF)-\u03b21. Sci Rep. 2016;6:28597.","journal-title":"Sci Rep"},{"issue":"1","key":"825_CR85","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s12943-017-0648-1","volume":"16","author":"Y Zhao","year":"2017","unstructured":"Zhao Y, Hu X, Liu Y, Dong S, Wen Z, He W, Zhang S, Huang Q, Shi M. ROS signaling under metabolic stress: cross-talk between AMPK and AKT pathway. Mol Cancer. 2017;16(1):79.","journal-title":"Mol Cancer"},{"key":"825_CR86","doi-asserted-by":"publisher","first-page":"110628","DOI":"10.1016\/j.mce.2019.110628","volume":"500","author":"H Ren","year":"2020","unstructured":"Ren H, Shao Y, Wu C, Ma X, Lv C, Wang Q. Metformin alleviates oxidative stress and enhances autophagy in diabetic kidney disease via AMPK\/SIRT1-FoxO1 pathway. Mol Cell Endocrinol. 2020;500:110628.","journal-title":"Mol Cell Endocrinol"},{"issue":"1","key":"825_CR87","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s12933-020-01041-4","volume":"19","author":"M Packer","year":"2020","unstructured":"Packer M. Autophagy-dependent and -independent modulation of oxidative and organellar stress in the diabetic heart by glucose-lowering drugs. Cardiovasc Diabetol. 2020;19(1):62.","journal-title":"Cardiovasc Diabetol"},{"issue":"8","key":"825_CR88","doi-asserted-by":"publisher","first-page":"e0183506","DOI":"10.1371\/journal.pone.0183506","volume":"12","author":"AA Ara\u00fajo","year":"2017","unstructured":"Ara\u00fajo AA, Pereira ASBF, Medeiros CACX, Brito GAC, Leit\u00e3o RFC, Ara\u00fajo LS, Guedes PMM, Hiyari S, Pirih FQ. Ara\u00fajo J\u00fanior RF. Effects of metformin on inflammation, oxidative stress, and bone loss in a rat model of periodontitis. PLoS ONE. 2017;12(8):e0183506.","journal-title":"PLoS ONE"},{"issue":"6","key":"825_CR89","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1007\/s13402-018-0398-0","volume":"41","author":"P Sharma","year":"2018","unstructured":"Sharma P, Kumar S. Metformin inhibits human breast cancer cell growth by promoting apoptosis via a ROS-independent pathway involving mitochondrial dysfunction: pivotal role of superoxide dismutase (SOD). Cell Oncol (Dordr). 2018;41(6):637\u201350.","journal-title":"Cell Oncol (Dordr)"},{"issue":"1","key":"825_CR90","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1080\/01480545.2019.1658769","volume":"45","author":"SS Tripathi","year":"2022","unstructured":"Tripathi SS, Singh S, Garg G, Kumar R, Verma AK, Singh AK, Bissoyi A, Rizvi SI. Metformin ameliorates acetaminophen-induced sub-acute toxicity via antioxidant property. Drug Chem Toxicol. 2022;45(1):52\u201360.","journal-title":"Drug Chem Toxicol"},{"issue":"10","key":"825_CR91","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1111\/exd.14868","volume":"32","author":"MHM El-Komy","year":"2023","unstructured":"El-Komy MHM, Abdo NMK, Shamma RN, Bedair NI. Topical metformin 30% gel in the treatment of acne vulgaris in women, a split face, placebo-controlled study. Exp Dermatol. 2023;32(10):1663\u201373.","journal-title":"Exp Dermatol"},{"issue":"1","key":"825_CR92","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s40257-020-00565-5","volume":"22","author":"H Yen","year":"2021","unstructured":"Yen H, Chang YT, Yee FJ, Huang YC. Metformin therapy for acne in patients with polycystic ovary syndrome: a systematic review and meta-analysis. Am J Clin Dermatol. 2021;22(1):11\u201323.","journal-title":"Am J Clin Dermatol"},{"issue":"8","key":"825_CR93","first-page":"CD005552","volume":"8","author":"E Fraison","year":"2020","unstructured":"Fraison E, Kostova E, Moran LJ, Bilal S, Ee CC, Venetis C, Costello MF. Metformin versus the combined oral contraceptive pill for hirsutism, acne, and menstrual pattern in polycystic ovary syndrome. Cochrane Database Syst Rev. 2020;8(8):CD005552.","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"825_CR94","doi-asserted-by":"publisher","first-page":"e12953","DOI":"10.1111\/dth.12953","volume":"32","author":"S Robinson","year":"2019","unstructured":"Robinson S, Kwan Z, Tang MM. Metformin as an adjunct therapy for the treatment of moderate to severe acne vulgaris: A randomized open-labeled study. Dermatol Ther. 2019;32(4):e12953.","journal-title":"Dermatol Ther"},{"issue":"1","key":"825_CR95","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1111\/ced.12673","volume":"41","author":"G Fabbrocini","year":"2016","unstructured":"Fabbrocini G, Izzo R, Faggiano A, Del Prete M, Donnarumma M, Marasca C, Marciello F, Savastano R, Monfrecola G, Colao A. Low glycaemic diet and metformin therapy: a new approach in male subjects with acne resistant to common treatments. Clin Exp Dermatol. 2016;41(1):38\u201342.","journal-title":"Clin Exp Dermatol"},{"issue":"6","key":"825_CR96","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1093\/ced\/llad020","volume":"48","author":"P Kamboj","year":"2023","unstructured":"Kamboj P, Kaushik A, Handa S, Dutta P, Saikia UN, Pal A, De D. Effects of metformin on clinical, hormonal and relevant gene expression parameters in patients with acne: an observational study. Clin Exp Dermatol. 2023;48(6):617\u201322.","journal-title":"Clin Exp Dermatol"},{"issue":"2","key":"825_CR97","first-page":"83","volume":"79","author":"EA Gonz\u00e1lez-Mondrag\u00f3n","year":"2022","unstructured":"Gonz\u00e1lez-Mondrag\u00f3n EA, Ganoza-Granados LDC, Toledo-Bahena ME, Valencia-Herrera AM, Duarte-Abdala MR, Camargo-S\u00e1nchez KA, Mena-Cedillos CA. Acne and diet: a review of pathogenic mechanisms. Bol Med Hosp Infant Mex. 2022;79(2):83\u201390.","journal-title":"Bol Med Hosp Infant Mex"},{"key":"825_CR98","doi-asserted-by":"publisher","first-page":"383","DOI":"10.2147\/CCID.S451104","volume":"17","author":"X Ji","year":"2024","unstructured":"Ji X, Wu S, Zhao D, Bai Q, Wang Y, Gong K, Zheng H, Zhu M. Revealing the impact of gut microbiota on acne through Mendelian randomization analysis. Clin Cosmet Investig Dermatol. 2024;17:383\u201393.","journal-title":"Clin Cosmet Investig Dermatol"},{"key":"825_CR99","doi-asserted-by":"publisher","first-page":"109131","DOI":"10.1016\/j.biopha.2019.109131","volume":"118","author":"W Zhang","year":"2019","unstructured":"Zhang W, Xu JH, Yu T, Chen QK. Effects of berberine and metformin on intestinal inflammation and gut Microbiome composition in db\/db mice. Biomed Pharmacother. 2019;118:109131.","journal-title":"Biomed Pharmacother"},{"issue":"1","key":"825_CR100","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00535-016-1242-9","volume":"52","author":"M Sun","year":"2017","unstructured":"Sun M, Wu W, Liu Z, Cong Y. Microbiota metabolite short chain fatty acids, GPCR, and inflammatory bowel diseases. J Gastroenterol. 2017;52(1):1\u20138.","journal-title":"J Gastroenterol"},{"issue":"2","key":"825_CR101","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1016\/j.immuni.2018.12.018","volume":"50","author":"J Schulthess","year":"2019","unstructured":"Schulthess J, Pandey S, Capitani M, Rue-Albrecht KC, Arnold I, Franchini F, Chomka A, Ilott NE, Johnston DGW, Pires E, McCullagh J, Sansom SN, Arancibia-C\u00e1rcamo CV, Uhlig HH, Powrie F. The short chain fatty acid butyrate imprints an antimicrobial program in macrophages. Immunity. 2019;50(2):432\u2013e4457.","journal-title":"Immunity"},{"issue":"2","key":"825_CR102","doi-asserted-by":"publisher","first-page":"152","DOI":"10.21037\/hbsn.2019.09.03","volume":"9","author":"T Li","year":"2020","unstructured":"Li T, Chiang JYL. Bile acid-based therapies for non-alcoholic steatohepatitis and alcoholic liver disease. Hepatobiliary Surg Nutr. 2020;9(2):152\u201369.","journal-title":"Hepatobiliary Surg Nutr"},{"issue":"6","key":"825_CR103","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.4315\/0362-028X.JFP-11-456","volume":"75","author":"X He","year":"2012","unstructured":"He X, Zou Y, Cho Y, Ahn J. Effects of bile salt deconjugation by probiotic strains on the survival of antibiotic-resistant foodborne pathogens under simulated gastric conditions. J Food Prot. 2012;75(6):1090\u20138.","journal-title":"J Food Prot"},{"issue":"17","key":"825_CR104","doi-asserted-by":"publisher","first-page":"9512","DOI":"10.3390\/ijms22179512","volume":"22","author":"D Miricescu","year":"2021","unstructured":"Miricescu D, Badoiu SC, Stanescu-Spinu II, Totan AR, Stefani C, Greabu M. Growth factors, reactive oxygen species, and metformin-promoters of the wound healing process in burns? Int J Mol Sci. 2021;22(17):9512.","journal-title":"Int J Mol Sci"},{"issue":"2","key":"825_CR105","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1097\/01.sla.0000152013.23032.d1","volume":"241","author":"DC Gore","year":"2005","unstructured":"Gore DC, Wolf SE, Sanford A, Herndon DN, Wolfe RR. Influence of metformin on glucose intolerance and muscle catabolism following severe burn injury. Ann Surg. 2005;241(2):334\u201342.","journal-title":"Ann Surg"},{"issue":"4","key":"825_CR106","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.burns.2014.10.010","volume":"41","author":"EC Diaz","year":"2015","unstructured":"Diaz EC, Herndon DN, Porter C, Sidossis LS, Suman OE, B\u00f8rsheim E. Effects of Pharmacological interventions on muscle protein synthesis and breakdown in recovery from burns. Burns. 2015;41(4):649\u201357.","journal-title":"Burns"},{"issue":"8","key":"825_CR107","doi-asserted-by":"publisher","first-page":"3265","DOI":"10.1210\/jc.2019-00129","volume":"104","author":"M Cree-Green","year":"2019","unstructured":"Cree-Green M, Bergman BC, Cengiz E, Fox LA, Hannon TS, Miller K, Nathan B, Pyle L, Kahn D, Tansey M, Tichy E, Tsalikian E, Libman I, Nadeau KJ. Metformin improves peripheral insulin sensitivity in youth with type 1 diabetes. J Clin Endocrinol Metab. 2019;104(8):3265\u201378.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"825_CR108","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1186\/cc12678","volume":"17","author":"MG Jeschke","year":"2013","unstructured":"Jeschke MG. Clinical review: glucose control in severely burned patients - current best practice. Crit Care. 2013;17(4):232.","journal-title":"Crit Care"},{"issue":"5","key":"825_CR109","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1101\/gad.274142.115","volume":"30","author":"NP Young","year":"2016","unstructured":"Young NP, Kamireddy A, Van Nostrand JL, Eichner LJ, Shokhirev MN, Dayn Y, Shaw RJ. AMPK governs lineage specification through Tfeb-dependent regulation of lysosomes. Genes Dev. 2016;30(5):535\u201352.","journal-title":"Genes Dev"},{"issue":"2","key":"825_CR110","doi-asserted-by":"publisher","first-page":"325","DOI":"10.7150\/ijbs.29009","volume":"15","author":"H Wu","year":"2019","unstructured":"Wu H, Ding J, Li S, Lin J, Jiang R, Lin C, Dai L, Xie C, Lin D, Xu H, Gao W, Zhou K. Metformin promotes the survival of Random-Pattern skin flaps by inducing autophagy via the AMPK-mTOR-TFEB signaling pathway. Int J Biol Sci. 2019;15(2):325\u201340.","journal-title":"Int J Biol Sci"},{"issue":"2","key":"825_CR111","first-page":"655","volume":"11","author":"L Qing","year":"2019","unstructured":"Qing L, Fu J, Wu P, Zhou Z, Yu F, Tang J. Metformin induces the M2 macrophage polarization to accelerate the wound healing via regulating AMPK\/mTOR\/NLRP3 inflammasome singling pathway. Am J Transl Res. 2019;11(2):655\u201368.","journal-title":"Am J Transl Res"},{"issue":"4","key":"825_CR112","doi-asserted-by":"publisher","first-page":"60","DOI":"10.3390\/ph13040060","volume":"13","author":"SF Spampinato","year":"2020","unstructured":"Spampinato SF, Caruso GI, De Pasquale R, Sortino MA, Merlo S. The treatment of impaired wound healing in diabetes: looking among old drugs. Pharmaceuticals (Basel). 2020;13(4):60.","journal-title":"Pharmaceuticals (Basel)"},{"issue":"3","key":"825_CR113","doi-asserted-by":"publisher","first-page":"e0150900","DOI":"10.1371\/journal.pone.0150900","volume":"11","author":"F Ochoa-Gonzalez","year":"2016","unstructured":"Ochoa-Gonzalez F, Cervantes-Villagrana AR, Fernandez-Ruiz JC, Nava-Ramirez HS, Hernandez-Correa AC, Enciso-Moreno JA, Casta\u00f1eda-Delgado JE. Metformin induces cell cycle Arrest, reduced Proliferation, wound healing impairment in vivo and is associated to clinical outcomes in diabetic foot ulcer patients. PLoS ONE. 2016;11(3):e0150900.","journal-title":"PLoS ONE"},{"issue":"40","key":"825_CR114","doi-asserted-by":"publisher","first-page":"27692","DOI":"10.1074\/jbc.M114.592576","volume":"289","author":"V Nair","year":"2014","unstructured":"Nair V, Sreevalsan S, Basha R, Abdelrahim M, Abudayyeh A, Rodrigues Hoffman A, Safe S. Mechanism of metformin-dependent Inhibition of mammalian target of Rapamycin (mTOR) and Ras activity in pancreatic cancer: role of specificity protein (Sp) transcription factors. J Biol Chem. 2014;289(40):27692\u2013701.","journal-title":"J Biol Chem"},{"issue":"5","key":"825_CR115","doi-asserted-by":"publisher","first-page":"e1209","DOI":"10.1038\/cddis.2014.175","volume":"5","author":"BI P\u00e9rez-Revuelta","year":"2014","unstructured":"P\u00e9rez-Revuelta BI, Hettich MM, Ciociaro A, Rotermund C, Kahle PJ, Krauss S, Di Monte DA. Metformin lowers Ser-129 phosphorylated \u03b1-synuclein levels via mTOR-dependent protein phosphatase 2A activation. Cell Death Dis. 2014;5(5):e1209.","journal-title":"Cell Death Dis"},{"issue":"2","key":"825_CR116","doi-asserted-by":"publisher","first-page":"3194","DOI":"10.1021\/acsnano.1c11040","volume":"16","author":"Y Liang","year":"2022","unstructured":"Liang Y, Li M, Yang Y, Qiao L, Xu H, Guo B. pH\/Glucose dual responsive metformin release hydrogel dressings with adhesion and self-healing via dual-dynamic bonding for athletic diabetic foot wound healing. ACS Nano. 2022;16(2):3194\u2013207.","journal-title":"ACS Nano"},{"issue":"24","key":"825_CR117","doi-asserted-by":"publisher","first-page":"4094","DOI":"10.3390\/cells11244094","volume":"11","author":"L Shi","year":"2022","unstructured":"Shi L, Jiang Z, Li J, Lin H, Xu B, Liao X, Fu Z, Ao H, Guo G, Liu M. Metformin improves burn wound healing by modulating microenvironmental fibroblasts and macrophages. Cells. 2022;11(24):4094.","journal-title":"Cells"},{"key":"825_CR118","first-page":"323","volume":"26","author":"Y Zhang","year":"2023","unstructured":"Zhang Y, Li M, Wang Y, Han F, Shen K, Luo L, Li Y, Jia Y, Zhang J, Cai W, Wang K, Zhao M, Wang J, Gao X, Tian C, Guo B, Hu D. Exosome\/metformin-loaded self-healing conductive hydrogel rescues microvascular dysfunction and promotes chronic diabetic wound healing by inhibiting mitochondrial fission. Bioact Mater. 2023;26:323\u201336.","journal-title":"Bioact Mater"},{"issue":"4","key":"825_CR119","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1080\/08982104.2018.1556291","volume":"29","author":"MS El-Ridy","year":"2019","unstructured":"El-Ridy MS, Yehia SA, Elsayed I, Younis MM, Abdel-Rahman RF, El-Gamil MA. Metformin hydrochloride and wound healing: from nanoformulation to Pharmacological evaluation. J Liposome Res. 2019;29(4):343\u201356.","journal-title":"J Liposome Res"},{"key":"825_CR120","first-page":"610","volume":"20","author":"Z Liu","year":"2022","unstructured":"Liu Z, Tang W, Liu J, Han Y, Yan Q, Dong Y, Liu X, Yang D, Ma G, Cao H. A novel sprayable thermosensitive hydrogel coupled with zinc modified metformin promotes the healing of skin wound. Bioact Mater. 2022;20:610\u201326.","journal-title":"Bioact Mater"},{"issue":"5","key":"825_CR121","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1111\/acel.12635","volume":"16","author":"P Zhao","year":"2017","unstructured":"Zhao P, Sui BD, Liu N, Lv YJ, Zheng CX, Lu YB, Huang WT, Zhou CH, Chen J, Pang DL, Fei DD, Xuan K, Hu CH, Jin Y. Anti-aging Pharmacology in cutaneous wound healing: effects of metformin, resveratrol, and Rapamycin by local application. Aging Cell. 2017;16(5):1083\u201393.","journal-title":"Aging Cell"},{"issue":"2","key":"825_CR122","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1007\/s00403-019-01982-1","volume":"312","author":"HM Tawfeek","year":"2020","unstructured":"Tawfeek HM, Abou-Taleb DAE, Badary DM, Ibrahim M, Abdellatif AAH. Pharmaceutical, clinical, and immunohistochemical studies of metformin hydrochloride topical hydrogel for wound healing application. Arch Dermatol Res. 2020;312(2):113\u201321.","journal-title":"Arch Dermatol Res"},{"key":"825_CR123","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1146\/annurev-pharmtox-051920-093829","volume":"62","author":"SNR Induri","year":"2022","unstructured":"Induri SNR, Kansara P, Thomas SC, Xu F, Saxena D, Li X. The gut microbiome, metformin, and aging. Annu Rev Pharmacol Toxicol. 2022;62:85\u2013108.","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"4","key":"825_CR124","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1007\/s12325-023-02434-z","volume":"40","author":"E Gouveri","year":"2023","unstructured":"Gouveri E, Papanas N. \u03a4he endless beauty of metformin: does it also protect from skin aging? A narrative review. Adv Ther. 2023;40(4):1347\u201356.","journal-title":"Adv Ther"},{"issue":"8","key":"825_CR125","doi-asserted-by":"publisher","first-page":"912","DOI":"10.3390\/ph15080912","volume":"15","author":"V Sorrenti","year":"2022","unstructured":"Sorrenti V, Benedetti F, Buriani A, Fortinguerra S, Caudullo G, Davinelli S, Zella D, Scapagnini G. Immunomodulatory and antiaging mechanisms of resveratrol, rapamycin, and metformin: focus on mTOR and AMPK signaling networks. Pharmaceuticals (Basel). 2022;15(8):912.","journal-title":"Pharmaceuticals (Basel)"},{"issue":"5","key":"825_CR126","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.3390\/nu12051529","volume":"12","author":"YJ Choi","year":"2020","unstructured":"Choi YJ. Shedding light on the effects of calorie restriction and its mimetics on skin biology. Nutrients. 2020;12(5):1529.","journal-title":"Nutrients"},{"issue":"2","key":"825_CR127","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s13105-018-0613-5","volume":"74","author":"T Soydas","year":"2018","unstructured":"Soydas T, Yaprak Sarac E, Cinar S, Dogan S, Solakoglu S, Tuncdemir M, Kanigur Sultuybek G. The protective effects of metformin in an in vitro model of aging 3T3 fibroblast under the high glucose conditions. J Physiol Biochem. 2018;74(2):273\u201381.","journal-title":"J Physiol Biochem"},{"issue":"3","key":"825_CR128","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s13105-021-00823-y","volume":"77","author":"T Soydas","year":"2021","unstructured":"Soydas T, Sayitoglu M, Sarac EY, C\u0131nar S, Solakoglu S, Tiryaki T, Sultuybek GK. Metformin reverses the effects of high glucose on human dermal fibroblasts of aged skin via downregulating RELA\/p65 expression. J Physiol Biochem. 2021;77(3):443\u201350.","journal-title":"J Physiol Biochem"},{"issue":"1","key":"825_CR129","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.jdermsci.2021.02.002","volume":"102","author":"T Xiao","year":"2021","unstructured":"Xiao T, Chen Y, Song C, Xu S, Lin S, Li M, Chen X, Gu H. Possible treatment for UVB-induced skin injury: Anti-inflammatory and cytoprotective role of metformin in UVB-irradiated keratinocytes. J Dermatol Sci. 2021;102(1):25\u201335.","journal-title":"J Dermatol Sci"},{"key":"825_CR130","doi-asserted-by":"publisher","first-page":"101583","DOI":"10.1016\/j.redox.2020.101583","volume":"37","author":"C Kremslehner","year":"2020","unstructured":"Kremslehner C, Miller A, Nica R, Nagelreiter IM, Narzt MS, Golabi B, Vorstandlechner V, Mildner M, Lachner J, Tschachler E, Ferrara F, Klavins K, Schosserer M, Grillari J, Haschemi A, Gruber F. Imaging of metabolic activity adaptations to UV stress, drugs and differentiation at cellular resolution in skin and skin equivalents - Implications for oxidative UV damage. Redox Biol. 2020;37:101583.","journal-title":"Redox Biol"},{"issue":"6","key":"825_CR131","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.1007\/s10787-022-01041-8","volume":"30","author":"DK Mostafa","year":"2022","unstructured":"Mostafa DK, Nayel OA, Abdulmalek S, Abdelbary AA, Ismail CA. Modulation of autophagy, apoptosis and oxidative stress: a clue for repurposing metformin in Photoaging. Inflammopharmacology. 2022;30(6):2521\u201335.","journal-title":"Inflammopharmacology"},{"issue":"12","key":"825_CR132","doi-asserted-by":"publisher","first-page":"3413","DOI":"10.1016\/j.celrep.2019.05.070","volume":"27","author":"M Chai","year":"2019","unstructured":"Chai M, Jiang M, Vergnes L, Fu X, de Barros SC, Doan NB, Huang W, Chu J, Jiao J, Herschman H, Crooks GM, Reue K, Huang J. Stimulation of hair growth by small molecules that activate autophagy. Cell Rep. 2019;27(12):3413\u201321.","journal-title":"Cell Rep"},{"issue":"3","key":"825_CR133","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1159\/000521400","volume":"35","author":"C Sun","year":"2022","unstructured":"Sun C, Hu SH, Dong BQ, Jiang S, Miao F, Lei TC. Metformin promotes the hair-inductive activity of three-dimensional aggregates of epidermal and dermal cells self-assembled in vitro. Skin Pharmacol Physiol. 2022;35(3):137\u201347.","journal-title":"Skin Pharmacol Physiol"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-026-00825-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s43440-026-00825-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s43440-026-00825-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T04:42:19Z","timestamp":1773204139000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s43440-026-00825-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,23]]},"references-count":133,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["825"],"URL":"https:\/\/doi.org\/10.1007\/s43440-026-00825-x","relation":{},"ISSN":["1734-1140","2299-5684"],"issn-type":[{"value":"1734-1140","type":"print"},{"value":"2299-5684","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,23]]},"assertion":[{"value":"20 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval, consent to participate and consent to publish"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}